Biz-Articles

Are you among the 43% of employers considering coverage of GLP-1s such as Wegovy for weight loss or Ozempic for diabetes medication for your workforce next year? If so, you need to ask yourself the following: Who should qualify for coverage? How do you monitor safe and effective use? Do you need to adjust your population health targets?

​

These questions can help you gain perspective on the true cost of diabetes, obesity and other chronic conditions and increase your understanding of a primary care’s critical role in a holistic care approach and the safe prescription of medications. In this webinar discussion, Accolade physicians discuss:

​

• Clinical guidance on rolling out GLP-1s out to your company.

• Key considerations for primary care physicians when diagnosing and deciding if GLP-1s are the right medication.

• Setting goals and expectations when it comes to a patient-centered support model.